Bristol Myers Squibb (BMY)
(Real Time Quote from BATS)
$41.51 USD
+0.63 (1.54%)
Updated Jun 7, 2024 10:44 AM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 181 - 200 ( 441 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 15
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 8
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 24
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 10
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D